Drug Profile
D 20566
Latest Information Update: 22 Aug 1997
Price :
$50
*
At a glance
- Originator ASTA Medica [CEASED]
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 01 Jun 1995 Discontinued-Preclinical for Cancer in Germany (Unknown route)